Feature

Biocompatible ‘lab on a chip’ shows potential in development of antiplatelet therapies

October 10, 2019
A novel biocompatible “lab-on-a-chip” device may help accelerate the discovery and development of new antiplatelet therapies, according…
Molecular Oncology

Precision oncology: Exciting clinical developments and complicated biology

HemOnc Today, October 10, 2019
Wafik S. El-Deiry, MD, PhD, FACP
Exciting developments in molecular oncology within the past few months include impressive clinical results of a novel drug that targets RET fusions…
Feature

Hope vs Hype: Managing Patient Expectations for CAR T-Cell Therapy

Cell Therapy Next, October/November 2019
Imagine a young adult male in his late 20s picks up his cell phone and calls his mother. Overtly emotional and on the verge of releasing a full-out…
Cover Story

Developing a Pause Button for CAR T-Cell Therapy

Cell Therapy Next, October/November 2019
Chimeric antigen receptor T-cell therapy has proven to be a life-changing development for those with advanced, treatment refractory leukemia and…
Feature

Formulation could reduce toxicities of head and neck cancer chemoradiotherapy

October 7, 2019
Researchers at Purdue University and Indiana University School of Medicine have developed a novel chemoradiotherapy formulation that could decrease…
Feature

Algorithm could help leverage data for pediatric oncology research

September 27, 2019
Investigators have developed an algorithm that appeared to accurately identify children with leukemia and lymphoma who would be appropriate for…
Cover Story

Growing incidence of Merkel cell carcinoma draws researchers’ attention

HemOnc Today, September 25, 2019
A dramatic increase in the rate of Merkel cell carcinoma has attracted new attention to this rare and aggressive skin cancer. Incidence of the…
Point/Counter

Is neoadjuvant immunotherapy the best treatment approach for regionally advanced Merkel cell carcinoma?

HemOnc Today, September 25, 2019
POINT Checkpoint inhibitors — specifically avelumab and pembrolizumab — have revolutionized the management of unresectable metastatic Merkel…
Feature

Neoadjuvant therapy may alter biliary microbiome in patients with pancreatic cancer

September 24, 2019
Patients with pancreatic cancer who received neoadjuvant therapy before pancreatoduodenectomy exhibited biliary microbiome alterations, according to…
Feature

Common cold virus could transform bladder cancer treatment

September 23, 2019
A novel therapeutic approach that involves the oncolytic virus coxsackievirus showed potential among a small cohort of patients with…